Sagiv Y - Search Results

1

Prioritizing replay when future goals are unknown.

Sagiv Y, Akam T, Witten IB, Daw ND. Sagiv Y, et al. bioRxiv [Preprint]. 2024 Mar 4:2024.02.29.582822. doi: 10.1101/2024.02.29.582822. bioRxiv. 2024. PMID: 38496674 Free PMC article. Preprint.

2

A feature-specific prediction error model explains dopaminergic heterogeneity.

Lee RS, Sagiv Y, Engelhard B, Witten IB, Daw ND. Lee RS, et al. Among authors: sagiv y. Nat Neurosci. 2024 Aug;27(8):1574-1586. doi: 10.1038/s41593-024-01689-1. Epub 2024 Jul 3. Nat Neurosci. 2024. PMID: 38961229

3

Distinct anti-inflammatory properties of alpha1-antitrypsin and corticosteroids reveal unique underlying mechanisms of action.

Schuster R, Motola-Kalay N, Baranovski BM, Bar L, Tov N, Stein M, Lewis EC, Ayalon M, Sagiv Y. Schuster R, et al. Among authors: sagiv y. Cell Immunol. 2020 Oct;356:104177. doi: 10.1016/j.cellimm.2020.104177. Epub 2020 Jul 24. Cell Immunol. 2020. PMID: 32795666

4

Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice.

Yarkoni S, Kaminitz A, Sagiv Y, Askenasy N. Yarkoni S, et al. Among authors: sagiv y. Diabetologia. 2010 Feb;53(2):356-68. doi: 10.1007/s00125-009-1604-4. Epub 2009 Nov 28. Diabetologia. 2010. PMID: 19946662

5

Interleukin 2 targeted therapy in inflammatory bowel disease.

Yarkoni S, Sagiv Y, Kaminitz A, Askenasy N. Yarkoni S, et al. Among authors: sagiv y. Gut. 2009 Dec;58(12):1705-6. doi: 10.1136/gut.2008.175182. Gut. 2009. PMID: 19923351 No abstract available.

6

A fusion protein composed of IL-2 and caspase-3 ameliorates the outcome of experimental inflammatory colitis.

Sagiv Y, Kaminitz A, Lorberboum-Galski H, Askenasy N, Yarkoni S. Sagiv Y, et al. Ann N Y Acad Sci. 2009 Sep;1173:791-7. doi: 10.1111/j.1749-6632.2009.04877.x. Ann N Y Acad Sci. 2009. PMID: 19758230

7

Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.

Yarkoni S, Sagiv Y, Kaminitz A, Farkas DL, Askenasy N. Yarkoni S, et al. Among authors: sagiv y. Eur J Immunol. 2009 Oct;39(10):2850-64. doi: 10.1002/eji.200839190. Eur J Immunol. 2009. PMID: 19735074 Free article.

8

Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen alphaGalCer.

Bai L, Sagiv Y, Liu Y, Freigang S, Yu KO, Teyton L, Porcelli SA, Savage PB, Bendelac A. Bai L, et al. Among authors: sagiv y. Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10254-9. doi: 10.1073/pnas.0901228106. Epub 2009 Jun 8. Proc Natl Acad Sci U S A. 2009. PMID: 19506241 Free PMC article.

9

Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression.

Yolcu ES, Ash S, Kaminitz A, Sagiv Y, Askenasy N, Yarkoni S. Yolcu ES, et al. Among authors: sagiv y. Immunol Cell Biol. 2008 Nov-Dec;86(8):650-8. doi: 10.1038/icb.2008.62. Epub 2008 Sep 16. Immunol Cell Biol. 2008. PMID: 18794907 Review.

10

Involvement of IL-2 in homeostasis of regulatory T cells: the IL-2 cycle.

Yarkoni S, Kaminitz A, Sagiv Y, Yaniv I, Askenasy N. Yarkoni S, et al. Among authors: sagiv y. Bioessays. 2008 Sep;30(9):875-88. doi: 10.1002/bies.20812. Bioessays. 2008. PMID: 18693266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters